The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies (2011)
Chapter: Appendix B: Agenda
B
Agenda
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Implications for Global Health and Opportunities for Novel Intervention Strategies
September 21–22, 2010
Keck Building, Room 100
500 Fifth Street, NW
Washington, DC
DAY 1: Tuesday, September 21, 2010
|
8:00–8:30: |
Registration and Continental Breakfast |
|
8:30–8:45: |
Welcoming Remarks |
|
|
David Relman, M.D., Chair, and James Hughes, M.D., Vice-Chair, Forum on Microbial Threats |
|
8:45–10:15: |
Keynote Remarks |
|
|
David Relman, Moderator |
|
8:45–9:30 |
Opportunities for medical diplomacy: The Global Health Initiative |
|
|
Ezekiel Emanuel, M.D., Ph.D., White House Office of Management and Budget |
|
9:30–10:15 |
NTDs slated for elimination and eradication |
|
|
Donald Hopkins, M.D., M.P.H., The Carter Center |
|
10:15–10:45: |
Discussion |
|
10:45–11:00: |
Break |
Session One:
An Overview of the NTDs
James Hughes, Moderator
|
11:00–11:30: |
Neglected infections of poverty in the United States |
|
|
Peter Hotez, M.D., Ph.D., The George Washington University |
|
11:30–12:00: |
NTDs in the setting of conflict |
|
|
Chris Beyrer, M.D., M.P.H., Johns Hopkins University |
|
12:00–12:30: |
Parasite prevalence and the worldwide distribution of cognitive ability |
|
|
Christopher Eppig, University of New Mexico |
|
12:30–1:00: |
Discussion of Session One |
|
1:00–1:45: |
Lunch |
Session Two:
Global Burden of Disease/Opportunities for Control
Mary Wilson, Moderator
|
1:45–2:15: |
The social and environmental context of infectious diseases occurrence in Brazil: Interventions, policies, and research needs |
|
|
Mauricio Barreto, M.D., M.P.H., Ph.D., Federal University of Bahia in Salvador, Brazil |
|
2:15–2:45: |
Neglected tropical and zoonotic diseases and their impact on women and children’s health |
|
|
Marian McDonald, Dr.P.H., M.P.H., M.A., Centers for Disease Control and Prevention |
|
2:45–3:15: |
Addressing the social determinants of the NTDs in devising an integrated control strategy |
|
|
Jerry Spiegel, Ph.D., M.A., M.Sc., University of British Columbia |
|
3:15–3:30: |
Break |
|
3:30–4:00: |
Reemergence of dengue in the United States? |
|
|
Harold Margolis, M.D., Centers for Disease Control and Prevention |
|
4:00–4:30: |
Chagas disease in the Americas: Health impacts and opportunities for control |
|
|
Rick L. Tarleton, Ph.D., The University of Georgia and The Chagas Disease Foundation |
|
4:30–5:00: |
Schistosomiasis |
|
|
Charles King, M.D., M.S., Case Western Reserve University |
|
5:00–5:30: |
Progress in the control and elimination of human African trypanosomiasis |
|
|
Jean Jannin, M.D., World Health Organization |
|
5:30–6:00: |
Integrated control of tropical diseases: Progress in the control and elimination of lymphatic filariasis |
|
|
Eric Ottesen, M.D., The Task Force for Global Health |
|
6:00–6:30: |
Discussion of Session Two; Open Discussion of Day One |
|
6:30: |
Adjourn |
DAY 2: September 22, 2010
|
8:00–8:15: |
Continental Breakfast |
|
8:15–8:30: |
Summary of Day One: James M. Hughes, M.D., Vice-Chair, Forum on Microbial Threats |
|
8:30–9:00: |
Keynote Remarks: Christy Hanson, Ph.D., U.S. Agency for International Development |
|
|
James M. Hughes, Moderator |
|
9:00–9:15: |
Discussion |
Session Three:
Governmental and Nongovernmental Approaches to Integrated Disease Control
Kevin Russell, Moderator
|
9:15–9:45: |
Neglected zoonotic diseases |
|
|
Lonnie King, D.V.M., The Ohio State University |
|
9:45–10:15: |
Regional approaches to NTD control in the Americas |
|
|
Steven Ault, Pan American Health Organization |
|
10:15–10:45: |
The neglected tropical diseases in Africa and next steps for global control and elimination |
|
|
Lorenzo Savioli, M.D., M.Sc., DTM&H, World Health Organization |
|
10:45–11:00: |
Break |
|
11:00–11:30: |
The U.K. commitment to NTD control |
|
|
Alan Fenwick, Imperial College of London |
|
11:30–12:00: |
The Gates Foundation commitment to NTD control |
|
|
Julie Jacobson, M.D., DTM&H, The Bill & Melinda Gates Foundation |
|
12:00–12:30: |
Discussion |
|
12:30–1:15: |
Luncheon Remarks: Jesse Goodman, M.D., M.P.H., Chief Scientist, Food and Drug Administration “Can we collaborate to develop new paradigms and approaches for public health product development and evaluation?” |
Session Four:
Unmet Needs: Development of Diagnostics, Drugs, and Vaccines to Control or Treat the Most Common NTDs
David Relman, Moderator
|
1:15–1:45: |
Public–private partnerships addressing diseases of the developing world: Lessons learned; current challenges; future opportunities |
|
Mark Feinberg, M.D., Ph.D., Merck & Co. |
|
1:45–2:15: |
New drugs in clinical development |
|
|
Shing Chang, Ph.D., DNDi |
|
2:15–2:45: |
Need for improved diagnostics |
|
|
Patrick Lammie, Ph.D., M.S., Centers for Disease Control and Prevention |
|
2:45–3:00: |
Break |
|
3:00–3:30: |
R&D Investments |
|
|
Mary Moran, M.D., Policy Cures, Sydney, Australia, London, UK |
|
3:30–4:00: |
Antihelminthic vaccines |
|
|
Peter Hotez, M.D., Ph.D., The George Washington University |
|
4:00–4:45: |
Open Panel Discussion |
|
4:45–5:00: |
Closing Remarks |
|
|
James Hughes and David Relman |
|
5:00: |
Meeting Adjourned |
